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CYTOKINES CHANGES IN THE
PATHOGENESIS OF ACUTE OR
EXACERBATED CHRONIC
PANCREATITIS CONSIDERING THE
ETIOLOGY AND GENDER
Abstract. To study the content of certain cytokines in the serum of
patients with acute or exacerbated chronic pancreatitis and,
considering the etiological factor and sex, 181 patients have been
examined. The study revealed the most pronounced increase in the
production of proinflammatory TNF- α 2.47 times with a
compensatory increase of anti-inflammatory cytokine IL-4 6.77 times,
which is exacerbated by alcohol genesis (the content increase of IL-4
8.98 times). For acute alcoholic edematous pancreatitis the
concentration increase of IL-1β with the predominant increase of IL-4
confirms the activation of humoral immunity. The course of acute
biliary edematous pancreatitis is accompanied by the higher levels of
systemic inflammatory reactions and is characterized by the higher
contents of TNF-α by 41.4% than of alcoholic genesis, at the lower
concentrations of IL-4 by 43.8%. For biliary edematous pancreatitis
the persons with exceeding standards of IL-1β ( χ2=9.52, p=0.002)
are more likely to occur by 16.74%, with no significant difference in
the frequency of TNF-α  and IL-4 considering the etiology of pancrea-
titis. Female gender is not associated with the increased levels of IL-
1β under alcoholic or biliary acute edematous pancreatitis and is a
potential factor in the protection of immune disorders.
Key words: pancreatitis, alcoholic,
biliary, cytokines, IL-4, TNF-α, IL-1β.
Introduction
Acute pancreatitis (AP) is one of the most spread
diseases today. The nosology, covering 15-20% of
patients with acute abdominal surgical pathology,
demonstrates in recent decades a clear trend of inci-
dence growth and prevalence (according to official
Ukrainian statistics - 102 cases per 100 thousand of
population [P.D. Fomin, 2012]. The increasing inci-
dence of AP and exacerbated chronic pancreatitis
(ECP) is mainly due to the increase of the incidence
of gall-stone disease and alcohol as the main etio-
logical factors of pancreatitis. At the same time, the
quality of diagnostics has improved.
Recently while considering the AP or ECP patho-
genesis, more attention is paid to the activation of
immune system.
The regularities of cytokines interaction have be-
come clear only in recent years, although the role of
inflammatory mediators in the pathogenesis of AP
was studied since 90-ies, but [9, 18]. So, the clinical
studies and the experimental data of pancreatitis rep-
roduction it has been shown that the key mediators
of the inflammation start-up are preimmune cyto-
kines TNF-α and immune (IL-1β, IL-6, IL-8, etc.).
Also, the same cytokine may cause the action of
different directions, depending on its concentration, a
specific type of receptor on the cell and its state of
activation. Alongside with this fact cytokines inte-
racting with specific receptors of cells can stimulate
or limit proliferation, differentiation, migration and
effector function of immune cells [1, 4; 5, 7].
To prevent excessive inflammatory reactions,
especially systemic inflammatory response syndro-
me, negative (feedback) control mechanisms related
to the production of anti-inflammatory cytokines (IL-
4, IL-10, IL-13) and soluble inhibitors of proinf-
lammatory cytokines are activated in the body. That
is, the ability to manage or control the cytokine balan-
ce can serve as another mechanism of influence on
the course and the complications occurrence of AP
[8, 13, 14]. Moreover, there is a number of expe-
rimental studies that have demonstrated the positive
effect of cytokine blockade on the destructive forms
of pancreatitis and the experience of the usage of
antycytokine drugs in the clinic [2, 16].
The purpose of the study
To estimate the content of cytokines TNF-α, IL-
1β, IL-4 in the peripheral blood of patients with AP
and ECP considering the etiology factor and gender.
Material and methods
The study involved the patients with AP and ECP
admitted to the emergency hospital of Chernivtsi du-
ring the last five years. The screening and diagnosis
of AP were carried out according to the current or-
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der of the Ministry of Health of Ukraine [3] and the
recommendations of the European Societies in diag-
nosis and treatment of acute pancreatitis [10, 11, 15].
181 patients with AP (edematous form) and ECP
have passed the screening step, they have signed the
informed consent of the patient to participate in the
study, with the following complex of clinical-labo-
ratory and diagnostic studies. Among the examined
there were 37 (20.4%) women and 144 (79.6%)
men. The mean age of patients was 45.1 ± 5.19
years for males, 53.7 ± 6.53 years for women (range
23-77). In order to fulfill the tasks, the patients were
divided into two groups, depending on the etiology:
alcohol or biliary genesis. Into the first group were
included 109 (60.2%) patients with the alcoholic ge-
nesis of pancreatitis (AGP), among whom there were
108 men and one woman; in the second - 72 (39.8%)
patients with the biliary genesis pancreatitis (BGP),
among whom there were 36 (50%) men and 36
(50%) women.
The control group consisted of 37 practically heal-
thy persons of corresponding age and sex, who du-
ring last 6 months did not have acute or the exacer-
bation of chronic inflammatory processes of any lo-
calization.
The level of interleukins IL-1β, IL-4 and the tu-
mor necrosis factor - alpha (TNF-α) were deter-
mined by the method of enzyme immuno-enzyme
assay (ELISA) using a set of reagents (Interleukin-4
ELISA-BEST) and by chemiluminescence analysis
(CLIA) using the Immulite F1427, Siemens. The
standard indexes for these cytokines were as follows:
IL-1β - <5 pg/ml; TNF-α - <8.1 pg/ml; IL-4 - 0-4
pg/ml. The concentration of the cytokines IL-1β and
TNF-α was determined in 181 patients, and IL-4 - in
90.
The statistical analysis was performed using
MYSTAT 12 (Systat Software Inc., USA) and
Scout 2008 Version 1.00.01 (U.S. Environmental
Protection Agency, USA). The reliability of data for
independent samples were calculated by t-test Stu-
dent (the distribution ranges close to normal) or U-
criterion Wilcoxon-Mann-Whitney (with uneven dist-
ribution). The analysis of qualitative features - by the
2 criterion. The difference was considered reliable at
p<0.05.
Discussion of the results
The study results of cytokines concentration in
the serum of patients with edematous pancreatitis
(EP) of different origins are shown in table 1.
An increase of proinflammatory cytokines con-
centrations of peripheral blood: IL-1β - by 27.25%,
TNF-α - 2.47 times (ð<0.001), as well as anti-
inflammatory (second generation) IL-4 - 6.77 times
(ð<0.01) is marked in patients with EP.
The concentration growth of IL-1β - the main
mediator of inflammatory reactions promotes the
deepening of the inflammatory processes and the
increase of TNF-α concentration indicates the acti-
Òàble 1
The concentration of cytokines in the serum of patients with edematous pancreatitis of
various genesis
Patients with edematous pancreatitis Cytokines, unit 
of measure 
Practically healthy 
people (n=37), M±m Exceeding norms, n (%) Data, M±m 
IL-1β, pg/ml 
4.11±0,05 27 (14,92%) 
5.23±0.024 
р<0.001 
TNF-α, pg/ml 
4.27±0,23 121 (66,85%) 
10.54±0.489 
р<0.001 
IL-4, pg/ml 
3.62±0,18 58 (64,44%) 
24.51±4.9 
р<0.004 
 vation of nonspecific proinfectious protection factors
and mechanisms. The higher concentrations of IL-4
may be explained by the increased immunosup-
pressive action.
A number of immuno-hematological parameters
have different meanings depending on the etiology of
EP. The results of studying of proinflammatory and
anti-inflammatory cytokines concentration in the peri-
pheral blood of patients with AGP are presented in
Table 2.
The concentration of IL-1β increases by 28.95%,
TNF-α - by 92.74% in peripheral blood of patients
with AGP. In addition to the increasing con-
centrations of proinflammatory (IL-1β and TNF-α),
the level of anti-inflammatory cytokine IL-4 inc-
reases 8.98 times which is synthesized by Th2, mast
cell (basophils). IL-4 induces proliferation of B-
lymphocytes and promotes the humoral immune res-
ponse and also stimulates the proliferation of Th2,
which form a humoral immune response.
The study results of pro- and anti-inflammatory
cytokines concentrations in the peripheral blood se-
rum of patients with BGP are shown in Table 3.
It is important that at BGP the concentration of
leading preimmune proinflammatory cytokines inc-
reases simultaneously: IL-1β and TNF-α by 26.52%
and 3.29 times respectively. Such growth of these
cytokines in patients with BGP results in the inc-
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reased production of acute phase inflammation pro-
teins by hepatocytes, including B-group of acute pha-
se proteins; increases the production of IL-2, IL-3,
IL-6, IL-8, colonystimulating factors, etc. The con-
centration growth of these interleukins points to the
inflammatory process deepening that develops into
staid character.
The growth of anti-inflammatory (immune) IL-4 in
5.04 times in the serum of patients with BGP shows
the possible stimulation of immunity system humoral
link, the growth of mast cells (tissue basophils), which
demonstrate a protective effect and also activates the
switching processes of plasma cells to the synthesis
of immunoglobulin E and other processes that show
immunosuppressive effect.
To determine the influence of etiology on pre-
immune and immune (inflammatory and anti-inflam-
matory) cytokines production we analyzed these cy-
tokines concentrations in the serum of peripheral
blood (Table 4).
It has been found that in the development of AGP
there is a more significant concentration growth of
IL-1β by 1.92% (p<0.05) and anti-inflammatory IL-
4 by 78.13% (p<0.05) than in BGP. However, higher
Òàble 2
The concentration of proinflammatory and anti-inflammatory cytokines in the peripheral
blood serum of patients with pancreatitis of alcoholic genesis
Patients with alcoholic genesis edematous 
pancreatitis, n=109 
Cytokines, unit 
of measure 
Practically healthy 
people (n=37), M±m 
Exceeding norms, n (%) Data, M±m 
IL-1β, pg/ml 4.11±0.05 9 (8.26%) 
5.3±0,041 
р<0.001 
TNF-α, pg/ml 4.27±0.23 76 (69.73%) 
8.23±0,244 
р<0.001 
IL-4, pg/ml 3.62±0.18 39 (67.2%)* 
32.49±5,2 
р<0.01 
Notes: * - of 58 examined patients with AGP 
 
Òàble 3
The concentration of proinflammatory and anti-inflammatory cytokines in the peripheral
blood serum of patients with pancreatitis of biliary genesis
Patients with biliary edematous pancreatitis, 
n=72 
Cytokines, 
units of 
measure 
Practically healthy 
people (n=37), M±m 
Exceeding norms, n (%) Data, M±m 
IL-1β, pg/ml 4,11±0,05 18 (25,0%) 
5,2±0,028 
р<0,001 
TNF-α, pg/ml 4,27±0,23 45 (62,5%) 
14,04±1,048 
р<0,001 
IL-4, pg/ml 3,62±0,18 19 (59,38%)* 
18,24±4,0 
р<0,01 
Notes: * - of 32 examined patients with BGP 
 
Òàble 4
Pre-immune and immune cytokines concentration in the peripheral blood serum of patients
with alcoholic and biliary pancreatitis
Patients with alcoholic edematous 
pancreatitis (n=109) 
Patients with biliary edematous 
pancreatitis (n=72) Cytokines, unit 
of measure Exceeding norms, 
n (%) 
Data, M±m 
Exceeding 
norms, n (%) 
Data, M±m 
9 (8.26%) 5.3±0.041 18 (25.0%) 5.2±0.028 IL-1β, pg/ml 
TNF-α, pg/ml р=0.046 
76 (69.73%) 8.23±0.244 45 (62.5%) 14.04±1.048 IL-4, pg/ml 
IL-1β, pg/ml р=0.0018 
39 (67.2%)* 32.49±5.2 19 (59.38%)** 18.24±4.0 TNF-α, pg/ml 
р=0.033 
Notes: * - of 58 examined patients with AGP, ** - of 32 examined patients with BGP, p – reliability of differences 
between the AGP and BGP groups 
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by 70.60% (p<0.05) concentration of TNF-α was
observed at BGP.
Such multidirectional changes, in our opinion, can
be explained as follows: first, alcohol limits the syn-
thesis of TNF-α, and secondly, for BGP is available
biliary-pancreatic reflux, in which the production of
proinflammatory cytokine is supported and depends
directly on the getting of bile in Wirsung duct [7].
Thus, the AGP is accompanied by the increased
concentration of the proinflammatory IL-1β and anti-
inflammatory IL-4 that improve the function of T-
CD4+ lymphocytes, realize the proliferation of acti-
vated B-lymphocytes and regulate the function of
monocytes and macrophages. BGP is characterized
by the increased concentration of TNF-α, which re-
gulates inflammatory processes depending on its
concentration in blood. For low concentrations, TNF-
α increases the synthesis of adhesion molecules of
epithelial cells, allowing neutrophil granulocytes
attach to the walls of blood vessels at the inflam-
mation site, followed by diapedesis in inflammation
place. For high concentrations it is an important me-
diator, indicating a high level of systemic reactions
associated with inflammation and can lead to endo-
toxin-induced septic state [5, 12, 17, 19].
The analysis of exceeding norm frequency of the
selected cytokines in patients with EP showed that
the content of TNF-α was exceeded in 121 (66.85%)
patients (of them - 62.81% of patients with AGP and
37.19% with BGP) of 181 patients. Moreover, the
excess of standards of TNF-α was observed in
69.73% of patients with AGP and in 62.5% of pa-
tients with BGP. The gender distribution revealed the
following: among the patients with AGP exceeding
standards were observed in 69.4% of men and the
only one woman (100.0%), whereas among the pa-
tients with BGP the exceeding of the normal range of
TNF-α was observed significantly more frequently
among the men (75%), than women (50%) (χ2=4.8,
p=0.0285).
The exceeding standards of levels of anti-inflam-
matory cytokine IL-4 in the peripheral blood of pa-
tients with EP was found in 64.44% of patients. And
if among the patients with AGP the excess of the
normal range was observed in 67.2% of patients,
among the patients with BGP - only in 59.38% of
individuals. The gender distribution revealed the follo-
wing: among the patients with AGP the exceeding
standards were observed in 66.7% of men and the
only one woman (100.0%), whereas among the pa-
tients with BGP the excess of the normal range of
IL-4 was observed only in 52.9% of men and 66.7%
women (χ2 2=0.62, ð=0.4302).
A somewhat different situation was observed in
the frequency of high concentrations of proinflam-
matory cytokine IL-1β: the excess concentration of
IL-1β was found only in 14.92% of patients. The ex-
cess of the normal range among the patients with
AGP was observed in 8.3% of patients (all male),
and among the patients with BGP - in 25% of pa-
tients (all male), representing 50% of all men with
BGP. It should be noted that in no woman was ob-
served an increase in the concentration of IL-1β by
BGP or AGP. The results, in our opinion, can be ex-
plained by the fact that TNF-α induces the synthesis
of some neurotrophic factors, including IL-1β. The-
refore, it is logical to assume that the synthesis of IL-
1β is slightly behind in time, as to the initial reaction of
the increase of TNF-α.
Conclusions
1.Edematous acute pancreatitis is accompanied
by the growth of production of proinflammatory
TNF- α 2.47 times with a compensatory increase of
anti-inflammatory cytokine IL-4 6.77 times, which is
exacerbated with alcohol genesis (increase of the
content of IL-4 8.98 times).
2.With alcoholic acute edematous pancreatitis the
increase of the concentration of IL-1β with a
predominant increase of IL-4 confirms the activation
of humoral immunity. The course of biliary acute
edematous pancreatitis is accompanied by the higher
levels of systemic inflammatory reactions and is
characterized by the higher contents of TNF-α by
41.4% than with alcoholic genesis, at the lower con-
centrations of IL-4 by 43.8%.
3.With biliary edematous pancreatitis significantly
more often by 16.74% are met persons with the ex-
cess of standard norms of IL-1β (χ2=9.58, p=0.002),
with no significant difference in the frequency of
TNF-α and IL-4 considering the etiology of pancr-
eatitis. Female sex is not associated with the inc-
reased levels of IL-1β neither alcoholic, nor biliary
acute edematous pancreatitis and it is a potential fac-
tor in the protection of immune disorders.
Prospects for further research
The determination of the possible genetic mecha-
nisms of immunological disorders formation for acute
pancreatitis considering the etiology and gender.
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ÈÇÌÅÍÅÍÈß ÍÅÊÎÒÎÐÛÕ ÖÈÒÎÊÈÍÎÂ Â
ÏÀÒÎÃÅÍÅÇÅ ÎÑÒÐÎÃÎ ÈËÈ ÎÁÎÑÒÐÅÍÈß
ÕÐÎÍÈ×ÅÑÊÎÃÎ ÏÀÍÊÐÅÀÒÈÒÀ Ñ Ó×¨ÒÎÌ
ÝÒÈÎËÎÃÈÈ È ÏÎËÀ
Ñ.È. Èâàùóê, Ë.Ï. Ñèäîð÷óê
Ðåçþìå. Ñ öåëüþ èçó÷åíèÿ ñîäåðæàíèÿ îòäåëüíûõ
öèòîêèíîâ â ñûâîðîòêå êðîâè áîëüíûõ ñ îñòðûì ïàíê-
ðåàòèòîì è îáîñòðåíèåì õðîíè÷åñêîãî, ñ ó÷¸òîì ýòèîëî-
ãè÷åñêîãî ôàêòîðà è ïîëà, îáñëåäîâàí 181 áîëüíîé. Âûÿâëåí
íàèáîëåå âûðàæåííûé ðîñò ïðîäóêöèè ïðîâîñïàëèòåëüíîãî
TNF-  â 2,47 ðàçà ñ êîìïåíñàòîðíûì óâåëè÷åíèåì ïðîòèâî-
âîñïàëèòåëüíîãî öèòîêèíà IL-4 â 6,77 ðàçà, ÷òî óñèëèâàåòñÿ
ïðè àëêîãîëüíîì ãåíåçå (ðîñò ñîäåðæàíèÿ IL-4 â 8,98 ðàçà).
Ïðè àëêîãîëüíîì îñòðîì îò¸÷íîì ïàíêðåàòèòå ðîñò êîí-
öåíòðàöèè IL-1β ñ ïðåèìóùåñòâåííûì óâåëè÷åíèåì IL-4
ñâèäåòåëüñòâóåò îá àêòèâàöèè ïîêàçàòåëåé ãóìîðàëüíîãî
çâåíà èììóíèòåòà. Òå÷åíèå áèëèàðíîãî îñòðîãî îò¸÷íîãî
ïàíêðåàòèòà ñîïðîâîæäàåòñÿ áîëåå âûñîêèì óðîâíåì
ñèñòåìíûõ âîñïàëèòåëüíûõ ðåàêöèé è õàðàêòåðèçóåòñÿ áîëåå
âûñîêèì ñîäåðæàíèåì TNF-α íà 41,4%, íåæåëè ïðè àëêî-
ãîëüíîì ãåíåçå, è áîëåå íèçêîé íà 43,8% êîíöåíòðàöèè IL-4.
Ïðè áèëèàðíîì îò¸÷íîì ïàíêðåàòèòå äîñòîâåðíî ÷àùå íà
16,74% âñòðå÷àþòñÿ ëèöà ñ ïðåâûøåíèåì íîðìû IL-1β (χ2
=9,52, ð=0,002), áåç äîñòîâåðíîé ðàçíèöû â ÷àñòîòå TNF-α
è IL-4 ñ ó÷¸òîì ýòèîëîãèè ïàíêðåàòèòà. Æåíñêèé ïîë íå
àññîöèèðóåò ñ ïîâûøåíèåì óðîâíÿ IL-1β íè ïðè àëêî-
ãîëüíîì, íè ïðè áèëèàðíîì îñòðîì îò¸÷íîì ïàíêðåàòèòå è
åñòü ïîòåíöèàëüíûì ôàêòîðîì çàùèòû èììóííûõ íàðó-
øåíèé.
Êëþ÷åâûå ñëîâà: ïàíêðåàòèò, àëêîãîëüíûé, áèëèàðíûé,
öèòîêèíû, IL-4, TNF-α, IL-1β.
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Ðåçþìå. Ç ìåòîþ âèâ÷åííÿ âì³ñòó îêðåìèõ öèòîê³í³â ó
ñèðîâàòö³ êðîâ³ õâîðèõ íà ãîñòðèé ïàíêðåàòèò ³ çàãîñòðåííÿ
õðîí³÷íîãî, ç óðàõóâàííÿì åò³îëîã³÷íîãî ÷èííèêà òà ñòàò³,
îáñòåæåíî 181 õâîðèé. Âèÿâëåíî íàéá³ëüø âèðàæåíå
çðîñòàííÿ ïðîäóêö³¿ ïðîçàïàëüíîãî TNF-α ó 2,47 ðàçà ³ç
êîìïåíñàòîðíèì çá³ëüøåííÿì ïðîòèçàïàëüíîãî öèòîê³íó IL-
4 ó 6,77 ðàçà, ùî ïîñèëþºòüñÿ çà àëêîãîëüíîãî ´åíåçó
(çðîñòàííÿ âì³ñòó IL-4 ó 8,98 ðàçà). Çà àëêîãîëüíîãî
ãîñòðîãî íàáðÿêîâîãî ïàíêðåàòèòó çðîñòàííÿ êîíöåíòðàö³¿
IL-1β ³ç ïåðåâàæíèì çá³ëüøåííÿì IL-4 çàñâ³ä÷óº àêòèâàö³þ
ïîêàçíèê³â ãóìîðàëüíî¿ ëàíêè ³ìóí³òåòó. Ïåðåá³ã á³ë³àðíîãî
ãîñòðîãî íàáðÿêîâîãî ïàíêðåàòèòó ñóïðîâîäæóºòüñÿ âèùèì
ð³âíåì ñèñòåìíèõ çàïàëüíèõ ðåàêö³é ³ õàðàêòåðèçóºòüñÿ
âèùèì âì³ñòîì TNF-α íà 41,4%, í³æ çà àëêîãîëüíîãî ´ åíåçó,
çà íèæ÷î¿ êîíöåíòðàö³¿ IL-4 íà 43,8%. Çà á³ë³àðíîãî
íàáðÿêîâîãî ïàíêðåàòèòó â³ðîã³äíî ÷àñò³øå íà 16,74%
çóñòð³÷àþòüñÿ îñîáè ³ç ïåðåâèùåííÿì íîðìè IL-1β (χ2=9,52,
ð=0,002), áåç â³ðîã³äíî¿ ð³çíèö³ ó ÷àñòîò³ TNF-α ³ IL-4 ç
óðàõóâàííÿì åò³îëîã³¿ ïàíêðåàòèòó. Æ³íî÷à ñòàòü íå àñîö³þº
ç ï³äâèùåííÿì ð³âíÿ IL-1? í³ çà àëêîãîëüíîãî, í³ çà á³ë³àð-
íîãî ãîñòðîãî íàáðÿêîâîãî ïàíêðåàòèòó ³ º ïîòåíö³éíèì
÷èííèêîì ïðîòåêö³¿ ³ìóííèõ ïîðóøåíü.
Êëþ÷îâ³ ñëîâà: ïàíêðåàòèò, àëêîãîëüíèé, á³ë³àðíèé,
öèòîê³íè, IL-4, TNF-α, IL-1β.
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